


Ask a doctor about a prescription for APIXABAN NORMOGEN 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Apixaban Normogen 5mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Apixaban Normogen contains the active substance apixaban and belongs to a group of medications called anticoagulants. This medication helps prevent the formation of blood clots by blocking Factor Xa, an important element in blood coagulation.
Apixaban Normogen is used in adults:
Do not take Apixaban Normogen if:
a recent or active stomach or intestinal ulcer, or recent cerebral hemorrhage);
Warnings and precautions
Tell your doctor, pharmacist, or nurse before taking this medication if you have any of these conditions:
Be careful with Apixaban Normogen
If you need to undergo surgery or a procedure that may cause bleeding, your doctor will instruct you to temporarily stop taking this medication for a period. If you are unsure whether a procedure may cause bleeding, consult your doctor.
Children and adolescents
This medication is not recommended for use in children and adolescents under 18 years of age.
Using Apixaban Normogen with other medications
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or may need to use other medications.
Some medications may increase the effects of Apixaban Normogen, and some medications may decrease its effects. Your doctor will decide if you should be treated with Apixaban Normogen if you are taking these medications and if you should be monitored more closely.
The following medications may increase the effects of Apixaban Normogen and increase the possibility of unwanted bleeding:
The following medications may reduce the ability of Apixaban Normogen to prevent blood clot formation:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor, pharmacist, or nurse before using this medication.
The effects of Apixaban Normogen on pregnancy and the fetus are unknown. You should not take this medication if you are pregnant. Tell your doctor immediatelyif you become pregnant while taking this medication.
It is unknown whether Apixaban Normogen is excreted in human milk. Ask your doctor, pharmacist, or nurse before taking this medication during breastfeeding. They will tell you whether to interrupt breastfeeding or whether to stop or not start taking this medication.
Driving and using machines
Apixaban Normogen has no influence on the ability to drive or use machines.
Apixaban Normogen contains lactose (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, talk to them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor, pharmacist, or nurse.
Dosage
Take the tablet with water. Apixaban Normogen can be taken with or without food. Try to take the tablets at the same time each day to achieve a better treatment effect.
If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take Apixaban Normogen. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.
Crushing instructions:
If necessary, your doctor may also administer the crushed Apixaban Normogen tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.
Take Apixaban Normogen according to the following recommendations:
To prevent the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.
The recommended dose of Apixaban Normogen is one Apixaban Normogen 5mgtablet twice a day.
The recommended dose is one Apixaban Normogen 2.5mgtablet twice a day if:
The recommended dose is one tablet twice a day, for example, take one tablet in the morning and one in the evening.
Your doctor will tell you how long you should continue treatment.
To treat blood clots in the veins of the legs and in the blood vessels of the lungs
The recommended dose is twoApixaban Normogen 5mgtablets twice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening.
After 7 days, the recommended dose is one Apixaban Normogen 5mgtablet twice a day, for example, one tablet in the morning and one in the evening.
To prevent blood clots from recurring after 6 months of treatment
The recommended dose is one Apixaban Normogen 2.5mgtablet twice a day, for example, one tablet in the morning and one in the evening.
Your doctor will tell you how long you should continue treatment.
Your doctor may change your anticoagulant treatment as follows:
Stop taking Apixaban Normogen. Start treatment with anticoagulant medications (e.g., heparin) at the time you would take the next Apixaban Normogen tablet.
Stop taking anticoagulant medications. Start treatment with Apixaban Normogen at the time you would take the next dose of an anticoagulant medication, and then continue as usual.
Stop taking the medication that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking Apixaban Normogen.
If your doctor tells you to start taking a medication that contains a vitamin K antagonist, continue taking Apixaban Normogen for at least 2 days after your first dose of the medication that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking Apixaban Normogen.
Patients undergoing cardioversion
If your heartbeat needs to be restored through a process called cardioversion, take this medication at the times your doctor indicates to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.
If you take more Apixaban Normogen than you should
Tell your doctor immediatelyif you have taken a dose greater than the prescribed dose of Apixaban Normogen. Bring the medication package to your doctor, even if there are no tablets left.
If you take more Apixaban Normogen than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse anti-factor Xa activity may be necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Apixaban Normogen
If you have doubts about what to do or if you forget to take more than one dose, ask your doctor, pharmacist, or nurse.
If you interrupt treatment with Apixaban Normogen
Do not interrupt treatment with this medication without talking to your doctor first, as the risk of developing a blood clot may be greater if treatment is interrupted too soon.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. The most frequent adverse effect of this medicine is bleeding, which can put the patient's life at risk and requires immediate medical attention.
The following adverse effects have been reported when taking Apixabán Normogen to prevent the formation of blood clots in the heart in patients with irregular heartbeats and at least one additional risk factor.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Infrequent Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Very Rare Adverse Effects (may affect up to 1 in 10,000 people)
Frequency Not Known (cannot be estimated from available data)
The following adverse effects have been reported when taking Apixabán Normogen to treat or prevent blood clots from recurring in the veins of the legs and blood vessels of the lungs.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Infrequent Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Bleeding:
Frequency Not Known (cannot be estimated from available data)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date shown on the packaging and on each blister after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Apixabán Normogen
Tablet core: anhydrous lactose; microcrystalline cellulose (type 14); microcrystalline cellulose (type 101); sodium croscarmellose; sodium lauryl sulfate; magnesium stearate. See section 2 "Apixabán Normogen contains lactose (a type of sugar) and sodium".
Tablet film coating: lactose monohydrate; hypromellose (E464); titanium dioxide (E171); triacetin; red iron oxide (E172).
Appearance and Package Contents
The film-coated tablets are pink and oval, measuring 11.0 mm ± 0.2 mm in length and 6.2 mm ± 0.2 mm in width.
They are presented in blisters within cartons containing 28 and 60 film-coated tablets.
Only some package sizes may be marketed.
Patient Information Card: Information Management
Inside the packaging of Apixabán Normogen, along with the prospectus, you will find a Patient Information Card or your doctor may give you a similar card.
This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with Apixabán Normogen. You should keep this card with you at all times .
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Manufacturer
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, n.º 2
Abrunheira, 2710-089 Sintra
Portugal
This medicine is authorized in EEA member states under the following names:
Spain, Apixabán Normogen 5 mg film-coated tablets EFG
Portugal, Apixabano Normogen
Date of the last revision of this prospectus:
December 2022
Other Sources of Information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for APIXABAN NORMOGEN 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.